| abstract |
Disclosed herein are antisense compounds and methods for treating or preventing thromboembolic complications, hyperproliferative disorders, or inflammatory conditions in an individual in need of reducing factor 7 . Examples of medical conditions that can be ameliorated by the administration of antisense compounds targeting factor 7 include thrombosis, embolism, and thromboembolism such as deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, cancer Rheumatoid arthritis, and fibrosis. |